HIGH BLEEDING RISK(HBR)
Clinical trials for HIGH BLEEDING RISK(HBR) explained in plain language.
Never miss a new study
Get alerted when new HIGH BLEEDING RISK(HBR) trials appear
Sign up with your email to follow new studies for HIGH BLEEDING RISK(HBR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Trial tests cutting blood thinner time to protect heart patients
Disease control Not yet recruitingThis study is for people who have had a heart attack and received a stent, but are at high risk for both future clots and serious bleeding. It will test if using a special stent and only one month of strong blood thinners is as safe and effective as using standard stents with a f…
Matched conditions: HIGH BLEEDING RISK(HBR)
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Major heart study aims to Fine-Tune Blood-Thinner use for safer recovery
Knowledge-focused Not yet recruitingThis study aims to understand and improve the real-world use of dual blood-thinning therapy (DAPT) in patients who have had a heart attack and received a stent. It will follow 3,500 patients at high risk for bleeding for one year to see how their treatment is managed and to test …
Matched conditions: HIGH BLEEDING RISK(HBR)
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:24 UTC